Cargando…
Cost and Utilization of Behavioral Health Medications Associated with Rescission of an Exemption for Prior Authorization for Severe and Persistent Mental Illness in the Vermont Medicaid Program
BACKGROUND: In recent years, many state Medicaid programs have implemented preferred drug lists (PDL) to control pharmaceutical costs by generating supplemental rebate revenues and directing providers to the most cost-effective treatments. Two states, Michigan and Vermont, sought approval from the C...
Autores principales: | Simeone, Jason C., Marcoux, Rita M., Quilliam, Brian J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437379/ https://www.ncbi.nlm.nih.gov/pubmed/20518584 http://dx.doi.org/10.18553/jmcp.2010.16.5.317 |
Ejemplares similares
-
Pharmacy benefit considerations for continuous glucose monitoring acquisition: Vermont Medicaid experience
por: Hurteau, Lisa Brouillette, et al.
Publicado: (2023) -
Acupuncture for Chronic Pain in the Vermont Medicaid Population: A Prospective, Pragmatic Intervention Trial
por: Davis, Robert T, et al.
Publicado: (2018) -
Vermont
Publicado: (1896) -
Vermont
Publicado: (1896) -
Vermont
Publicado: (1896)